Avecho Biotechnology Ltd has released a press release.
Appendix 4C - Quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- Injectable Portfolio Update - Products Differentiated by TPM
- Terumo return rights to TPM/Propofol Injectable
- Ashland purchases manufacturing rights for Vital ET and TPM
- FDA meeting provides guidance for TPM/Oxymorphone patch
- Reinstatement to Offical Quotation
Later from Avecho Biotechnology
- Appendix 4E and Annual Report 31 December 2019
- Avecho signs Term Sheet for Cannabinoid Supply with Purisys
- Medicinal cannabis supply agreement with Tasmanian Alkaloids
- Changes to Leadership Team
- March 2020 Quarterly Activities Report & Appendix 4C
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology